Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
PNAS Nexus|July 14, 2022
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19Arjun Puranik, Patrick J Lenehan, John C O'Horo, et al.Nature Communications|August 16, 2017
Critical role for arginase 2 in obesity-associated pancreatic cancerTamara Zaytouni, Pei-Yun Tsai, Daniel S Hitchcock, et al.PNAS Nexus|January 30, 2023
Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19Arjun Puranik, Patrick J Lenehan, John C O'Horo, et al.Medrxiv : the Preprint Server for Health Sciences|December 16, 2022
Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditionsPritha Ghosh, Michiel J M Niesen, Colin Pawlowski, et al.Iscience|July 31, 2024
Case-control study on post-COVID-19 conditions reveals severe acute infection and chronic pulmonary disease as potential risk factorsPritha Ghosh, Michiel J M Niesen, Colin Pawlowski, et al.Scientific Reports|January 5, 2023
Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variantsA J Venkatakrishnan, Praveen Anand, Patrick J Lenehan, et al.Med (New York, N.Y.)|December 20, 2021
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infectionArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.JAMA Network Open|April 14, 2022
Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health RecordsMichiel J M Niesen, Colin Pawlowski, John C O'Horo, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent ImmunityKatherine S Ventre, Kevin Roehle, Elisa Bello, et al.The Journal of Clinical Investigation|August 19, 2021
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19Ravindra Ganesh, Colin F Pawlowski, John C O'Horo, et al.Pageof 4